General Announcement::ASX: TLX Telix Submits NDA for TLX101-CDx Brain Cancer Imaging Agent

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
28-Aug-2024 06:29:16
Status
New
Announcement Sub Title
ASX: TLX Telix Submits NDA for TLX101-CDx Brain Cancer Imaging Agent
Announcement Reference
SG240828OTHR0NF8
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
28/08/2024 08:30:00
Description (Please provide a detailed description of the event in the box below)
ASX: TLX Telix Submits NDA for TLX101-CDx Brain Cancer Imaging Agent

Attachments

20240827 TLX101-CDx NDA Filing vFINAL.pdf
Total size =148K